Nutriband Inc. Stock Insider Power

Based on the 29 latest insides trades, we have calculated the insider power to be positive at 60.70. In total, the insiders bought 293 666 and sold 1 500 500 NTRB shares in the last 29 trades.

Insider Power

(Last 29 transactions)
60.70
Buy 293 666 Shares
Sell 1 500 500 Shares

Historical Insider Trades

Date Type Action Person Amount
Oct 27, 2023 Stock Option Buy Goodman Gerald 49 500
Mar 06, 2023 Common Stock, par value $0.001 per share Sell Melnik Serguei 5 000
Dec 09, 2022 Stock Option Buy Goodman Gerald 20 000
Aug 16, 2022 Stock Option Buy Goodman Gerald 23 333
May 10, 2022 Common Stock Buy Sheridan Gareth 10 000
May 10, 2022 Common Stock Sell Sheridan Gareth 10 000
Feb 24, 2022 Common Stock, par value $0.001 per share Buy Melnik Serguei 500
Feb 24, 2022 Common Stock, par value $0.001 per share Sell Melnik Serguei 500
Feb 24, 2022 Common Stock, par value $0.001 per share Sell Melnik Serguei 5 000
Feb 06, 2022 Common Stock, par value $0.001 per share Sell Melnik Serguei 10 000
Jan 21, 2022 Stock Option Buy Goodman Gerald 11 167
Jan 21, 2022 Options to Purchase Common Stock Buy Melnik Serguei 23 333
Jan 21, 2022 Options to Purchase Common Stock Buy Sheridan Gareth 23 333
Jan 21, 2022 Options to Purchase Common Stock Buy Melnik Serguei 20 000
Jan 21, 2022 Options to Purchase Common Stock Buy Sheridan Gareth 20 000
Oct 22, 2021 CS Purchase Warrant Buy Goodman Gerald 87 500
Jan 31, 2021 Buy Sheridan Gareth 0
May 30, 2019 Common Stock, par value $0.001 per share Sell Melnik Serguei 20 000
Jul 31, 2018 Common Stock, par value $0.001 per share Buy Davidov Michael 5 000
May 31, 2018 Buy Davidov Michael 0
Jan 31, 2018 Common Stock, par value $0. 001 per share Sell Melnik Serguei 0
Jan 31, 2018 Common Stock, par value $0.001 per share Buy Melnik Serguei 0
Jan 31, 2018 Common Stock, par value $0.001 per share Buy Melnik Serguei 0
Jan 31, 2018 Buy Sheridan Gareth 0
Aug 19, 2017 Common Stock Sell Melnik Serguei 450 000
Click to get the best stock tips daily for free!

About Nutriband Inc.

Nutriband. Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; e... NTRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT